Info

JAMA Clinical Reviews

Interviews about ideas & innovations in medicine, science & clinical practice. Listen & earn CME credit
RSS Feed Subscribe in Apple Podcasts
JAMA Clinical Reviews
2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May
April
March
February
January


2015
December
November
October
September
August
July
June
May


Categories

All Episodes
Archives
Categories
Now displaying: Page 1

In-depth interviews about current ideas and innovation in medicine, science, and clinical practice.

Apr 7, 2020

Eczema is extremely common in children. Most the time it is easily treated with topical steroids but on occasion it requires systemic therapies. JAMA Pediatrics Editor Dimitri Christakis, MD, MPH, and JAMA Network Open Editor Frederick Rivara, MD, MPH, discuss the results of a clinical trial of a new monoclonal antibody intended to improve eczema in children that was published in the January 2020 issue of JAMA Pediatrics.

Related:

Are Bacteria Transplants the Future of Eczema Therapy?

Effect of an Intervention to Promote Breastfeeding on Asthma, Lung Function, and Atopic Eczema at Age 16 Years: Follow-up of the PROBIT Randomized Trial

Persistence of Childhood Eczema Into Adulthood

Association Between Eczema and Stature in 9 US Population-Based Studies

Healthcare Utilization, Patient Costs, and Access to Care in US Adults With Eczema: A Population-Based Study

Management of Atopic Dermatitis

Anti-IgE Medication Lessens Pediatric Atopic Dermatitis Severity

Atopic Eczema

0 Comments
Adding comments is not available at this time.